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Abstract  
 
Person-centred care can improve the well-being of patients and is therefore a key 
driver in healthcare developments in the UK. The current study aims to investigate 
the complex relationship between cognitive impairment, dependency and well-
being in people with a wide range of acquired brain and spinal injuries. Sixty-five 
participants, with varied acquired brain and spinal injuries, were selected by 
convenience sampling from six inpatient clinical neuroscience settings. Participants 
were observed using Dementia Care Mapping – Neurorehabilitation (DCM-NR) and 
categorised based on severity of cognitive impairment. 
 
A significant difference in the behaviours participants engaged in, their wellbeing 
and dependency was found between the severe cognitive impairment group and 
the mild, moderate or no cognitive impairment groups. Dependency and cognitive 
impairment accounted for 23.9% of the variance in well–illbeing scores and 17.2% 
of the variance in potential for positive engagement. 
 
The current study highlights the impact of severe cognitive impairment and 
dependency on the behaviours patients engaged in and their well-being. It also 
affirms the utility of DCM-NR in providing insights into patient experience 
 
Consideration is given to developing DCM-NR as a process that may improve 
person-centred care in neuroscience settings. 
 
Keywords: Cognitive Impairment, DCM, Dementia Care Mapping, Dependency, 
Neurorehabilitation.  
  
3 
 
Introduction 
Person-centred care (PCC) has many definitions and indeed a range of 
synonymous terms such as individualised care and patient-centred care. The 
common theme across the many definitions of PCC is that the focus of healthcare 
should be on the person and not on their illness (Edvardsson & Innes, 2010).  
PCC has been a key driver in improving healthcare provision in the UK 
(Department of Health, 2010; The Scottish Government, 2010). While initially 
applied to the area of dementia care following the influence of Kitwood’s work on 
personhood (1997), PCC is recognised as being instrumental in providing the best 
care for those with a range of neurological conditions such as: stroke (NICE, 2008), 
head injury (NICE, 2007) as well as dementia (NICE, 2006).    
Kitwood’s work on PCC (1997) led to the development of Dementia Care Mapping 
(DCM), currently in its 8th edition (Bradford Dementia Group, 2005). DCM is a 
structured observational tool to measure the level of PCC people with dementia are 
receiving from within formal health and social care settings. It involves observing 
(called “mapping”) one or more individuals and periodically recording their 
behaviour into one of 23 behaviour category codes (BCC), determining their level 
of mood and engagement (ME values) in that activity as well as any significant 
interactions with staff. The mean of the ME values over the time period mapped is 
used as an indicator of that person’s state of well-being (Well–Ill-Being: WIB score) 
for that time period. In addition, the percentage of time spent engaging in 
behaviours that have potential for the individual to reach high levels of well-being 
can be calculated as potential for positive engagement (PPE). Research has 
demonstrated that DCM has good internal consistency, test-retest and inter-rater 
reliabilities as well as correlating with other measures of quality of life (Brooker, 
2005; Fossey, Lee & Ballard, 2002).   
DCM is also a process to promote and improve the level of PCC in health and 
social care settings. This is done by feeding back the observations and recordings 
to staff teams and subsequently developing action plans, which are implemented, 
monitored and further actions developed through subsequent cycles of mapping. 
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DCM relies on the premise that by improving PCC, the well-being and quality of life 
of the person with dementia will improve.  
A number of published studies report the beneficial effect DCM has on the well-
being of patients (Brooker, 2005; Brooker, Foster, Banner, Payne, & Jackson, 
1998). DCM has also been shown to impact on other indicators of well-being, such 
as reduced verbal and physical agitation and anxiety (Chenoweth & Jeon, 2007; 
Kuiper, Dijkstra, Tuinstra, & Groothoff, 2009), reduction in numbers of falls 
(Chenoweth et al., 2009) and decreased levels of depression (Chenoweth & Jeon, 
2007). Many studies have also shown that DCM can support staff in understanding 
the perspective of the person with dementia, leading to staff having increased 
confidence in implementing person-centred care (Beavis, Simpson, & Graham, 
2002; Mansah, Coulon, & Brown, 2008). Studies have also shown that DCM can 
result in care staff feeling more connected with patients (Kuiper et al., 2009) and 
can improve quality of staff–patient interactions (Chenoweth & Jeon, 2007). 
While DCM was originally devised for use in dementia care settings, research has 
successfully applied the DCM tool and methodology to a range of other healthcare 
settings and with different client groups. DCM has been implemented in learning 
disability residential services (Persaud & Jaycock, 2001) and hospital wards for 
patients with a variety of physical health problems (Woolley, Young, Green & 
Brooker, 2008). Despite DCM not being designed for use in these settings or with 
these patient groups, researchers found it to be both useful and effective in 
measuring PCC, well-being and, as an observational tool, in illustrating the 
activities in those care settings. Both studies suggested modifications to DCM so 
that it could be adapted for use in their respective healthcare settings. 
The similarities between people with dementia and people with acquired brain 
injury, such as cognitive, emotional and behavioural difficulties, are readily 
apparent. Therefore, recent research has investigated adapting DCM for use in 
neurorehabilitation settings (McIntosh et al. 2012; Westbrook, McIntosh, Sheldrick, 
Surr & Hare, 2013). Utilising Q-methodology alongside DCM in a 
neurorehabilitation ward it was concluded that DCM was feasible and acceptable 
for both staff and patients. Following these initial studies and the researchers’ 
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recommendations for amendments to DCM, a manual for using DCM in 
neurorehabilitation settings was devised: Care Mapping – Neurorehabilitation 
(DCM-NR: Bradford Dementia Group, 2012).  
Patients in clinical neuroscience vary in aetiology, including traumatic brain injury, 
stroke, epilepsy and spinal cord injury. The incidence of traumatic brain injury (TBI) 
is 235 per 100,000 (Tagliaferri et al. 2006), stroke is 104 per 100,000 (Lee, Shafe, 
Cowie, 2011), with spinal cord injuries less common with an estimated incidence of 
1 - 8.3 per 100,000 (Wyndaele & Wyndaele, 2006). Those who have suffered an 
acquired brain injury (ABI) can face a range of physical, behavioural, and socio-
economic disabilities (Finset & Andersson, 2000) that have a negative impact on 
their quality of life (Vickery, Gontkovsky & Caroselli, 2005; Andelic et al. 2009) and 
often require long-term care and rehabilitation. 
It is the cognitive and emotional sequelae after ABI are considered to be the 
hardest to adjust to and have the greatest impact on well-being (Franulic 
Carbonell, Pinto & Sepulveda. 2004). Some DCM research has looked at the effect 
of cognitive impairment on person-centered care and well-being, albeit in people 
with dementia. Much of this evidence is unclear with Edelman, Kuhn & Fulton 
(2004) finding those with greater cognitive impairment displaying lower well-being, 
while other researchers report no significant relationship between cognitive 
impairment and well-being or activity measured by DCM (Gigliotti, Jarrott & 
Yorgason, 2004; Jarrot & Bruno, 2003). Research in this area relies on measuring 
cognitive impairment accurately, with most studies using the Mini-Mental state 
examination (MMSE: Folstein, Folstein & McHugh, 1975) as the primary, or only 
measure of cognitive impairment.  
In addition to cognitive impairment, other factors influence well-being following ABI, 
principal of which is functional ability. ABI frequently has a negative impact on 
functional ability (Vickery et al.’ 2005) with researchers and governments alike 
recognising that traumatic brain injury is a predominant cause of disability, 
particularly in those under the age of 35 years (Seel et al., 2003). Unemployment 
following TBI ranges from 10 to 70% (McCrimmon & Oddy, 2006) and those that 
do return to work often do so in a different role than prior to their injury. Functional 
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ability, therefore, has a very large impact on well-being (Vickery et al., 2005), with 
those who have less functional ability being more likely to develop a psychological 
condition, such as depression or anxiety (Schonberger, Ponsford, Gould, & 
Johnston, 2011).  
Measuring functional ability in acute hospital settings is highly important for 
determining staffing levels and providing good quality care to patients. Thus, 
functional ability in acute hospital settings is seen as level of dependency, i.e., the 
level of support needed by staff or others to function. A widely used and validated 
measure of dependency is the Northwick Park Dependency Scale (Siegert & 
Turner-Stokes, 2010; Turner-Stokes et al., 1998). 
DCM research has started to investigate the complexity of functional ability or its 
inverse, dependency, and its relation to well-being. Higher dependency has been 
linked to lower well-ill-being scores (Edelman, et al., 2004) . Brooker et al. (1998) 
linked this relationship to a mediating factor of poorer care for those with higher 
dependency, finding that with three cycles of DCM the relationship of lower well-
being for those with more dependent patients was no longer significant. Brooker 
(2005) recommended the routine use of a measure of dependency alongside DCM 
to investigate this relationship further.  
NHS Trusts are currently being challenged to implement safer, better quality care 
in response to the findings of the Francis report (Francis, 2013) with person-
centred care a likely approach many NHS Trusts may choose to adopt. Research 
suggests that DCM can help to deliver PCC for people with dementia in NHS 
settings and more recent studies indicate DCM-NR may be a feasible and 
acceptable tool and process to use in clinical neuroscience settings, There remains 
a need to investigate whether there are similar patterns of effects of cognitive 
impairment and functional ability on well-being as measured through DCM-NR 
scores as seen in DCM studies. If this is the case then this indicates DCM-NR may 
not only be a useful process for helping staff to implement PCC, but may also 
provide valuable data about the impact of changes to care practice on patient well-
being.   
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This study aimed to investigate the relationships between cognitive impairment, 
dependency and well-being in a sample of patients from a range of clinical 
neuroscience settings. Three primary hypotheses were considered: 
 
Hypothesis 1: A negative relationship between dependency and the 
patient’s observed mood/engagement and potential for positive engagement 
(PPE). (1a) Greater mood and engagement (DCM: WIB scores) will be 
observed in those patients with less dependency, as measured by the 
Northwick Park Dependency Scale. (2b) Higher PPE score (DCM) will be 
observed in those patients with less dependency (NPDS). 
 
Hypothesis 2: A negative relationship between cognitive impairment and the 
patient’s observed mood/engagement and PPE. (2a) Greater mood and 
engagement (DCM: WIB scores) will be observed in those patients with less 
cognitive impairment. (2b) Higher PPE score (DCM) will be observed in 
those patients with less cognitive impairment. 
 
Hypothesis 3: A positive relationship will be seen between cognitive 
impairment and dependency. Those patients with greater cognitive 
impairment will also have greater levels of dependency, as measured by the 
NPDS.  
 
Method 
Participants 
A convenience sample of patients were recruited from six clinical neuroscience 
wards at Salford Royal NHS Foundation Trust, UK. The wards recruited from 
included diverse specialties: neurorehabilitation, neurosurgery, neurology, and 
stroke rehabilitation. Patients on these wards had a range of neurological 
conditions, including traumatic brain injury, cerebrovascular injuries, central 
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nervous system tumours, neuropathy, and spinal cord injuries. A description of the 
demographic details for the participants is contained in Table 1. 
An assessment of capacity to take part in the study was conducted with all 
participants. Consent was obtained from those with capacity and assent was 
gained from the nominated individual of those deemed to be lacking capacity to 
make the decision. Capacity was assessed on an on-going basis by a clinician 
(RS) qualified to do so, given the potential for participants to deteriorate or recover, 
over the course of the study.  
Exclusion criteria as a whole were limited to ensure the sample remained 
representative of the typical patients on the wards and exclusion criteria were not 
applied to the DCM-NR part of the study. Exclusion criteria were applied prior to 
any participant completing the Addenbrooke’s Cognitive Examination – Revised 
(ACE-R), these being under the age of 18, non-English speaking, in a minimally 
conscious state or in post-traumatic amnesia (PTA) preventing completion of the 
task, and obvious lack of suspected cognitive impairment. A total of 67 participants 
was recruited into the study, and observed using DCM-NR. Of these, cognitive 
assessment using the ACE-R was completed with 29, although severity of 
cognitive impairment was determined for the remainder.  
Table 1. Participant Demographics (n = 65) 
Participant Demographics (n=65) 
Age Mean (SD) 57.34 (18.24) years 
 Range 18 – 93 years 
Gender Male 18 (27.7%) 
 Female 47 (72.3%) 
Ethnicity  White British 54 (83.1%) 
Black British 5 (7.7%) 
Asian British 2 (3.1%) 
Other 4 (6.2%) 
Time Since Admission (days) Median (SD) 22 (61.02) days 
Range 0 – 328 days 
Cause of admission  Traumatic Brain Injury 11 (16.9%) 
Cerebrovascular 20 (30.8%) 
Spinal Cord Injury 11 (16.9%) 
Tumour 5   (7.7%) 
Other Neurological conditions 18 (27.7%) 
Northwick Park Dependency 
Scale (NPDS) 
Mean (SD) 28.03 (19.75) 
Range 0 - 72 
Severity of Cognitive 
Impairment  
None 29 (44.6%) 
Mild 10 (15.4%) 
Moderate 14 (21.5%) 
Severe 11 (16.9%) 
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Measures 
Dementia Care Mapping-Neurorehabilitation (DCM-NR). DCM-NR (Bradford 
Dementia Group, 2012) is an adapted version of Dementia Care Mapping 8th 
edition (DCM 8: Bradford Dementia Group, 2005) for use with neurological 
populations in a hospital setting. The DCM-NR was developed and its feasibility 
and acceptability on a neurorehabilitation ward was initially established by 
McIntosh et al. (2012) and Westbrook, McIntosh, Sheldrick, Surr, and Hare (2013). 
A further study (O’Hanlon, in preparation) has examined its feasibility for use on a 
broad range of neuroscience wards. 
Participants in a communal area, such as a ward bay, are observed for a length of 
time (2 ½ hours in this study). At three-minute intervals two recordings were made. 
(1) A Behaviour Category Code (BCC) is chosen from a list of 24 categories to 
record the behaviour the participant was engaged in during those 3 minutes. (2) 
the degree to which the participant was engaged in their behaviour and their mood 
is also recorded on a six-point scale from +5 to -5 (-5, -3, -1, +1, +3 and +5) (ME 
value). Any staff-participant interactions that either enhanced or diminished the 
person’s sense of self or well-being are also recorded independent of the time 
frame. Staff interactions with patients that enhance their well-being are recorded as 
personal enhancers (PEs) and interactions diminishing their well-being are 
recorded as personal detractors (PDs). PEs and PDs are categorised on Kitwood’s 
(1997) psychological needs: attachment, comfort, inclusion, occupation, and 
identity. 
Adaptions to the DCM 8 to create the first version of a tool suitable for testing in 
neurorehabilitation settings (DCM-NR) (Bradford Dementia Group, 2012) primarily 
centre around the adaptation to an acute setting. As such, a BCC code of “M” for 
Medical care was included, and of “p” and “t” codes for use alongside standard 
BCC codes to indicate that the “curtains were closed around the patient’s bed” or 
“therapeutic activity” was taking place respectively.  
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Further amendments were the use of 3 minute time intervals and a 2 ½  hour 
observation period. Fossey et al. (2002) showed that mapping over a shorter 
lunchtime period correlated well with longer full-day mapping. Fulton, Edelman, 
and Kuhn (2006) expanded upon this and found that shorter mapping periods were 
feasible. Therefore it was decided to employ a 2 ½ map (using 3 minute time-
frames) including a lunchtime period. As described, this was supported by previous 
research (Fossey et al., 2002; Fulton et al., 2006) while also satisfying DCM-NR 
requirements of a minimum of 48 time-frames for WIB and PPE calculations. 
Furthermore this methodology was agreed upon in collaboration with researchers 
at the Bradford Dementia Group and deemed acceptable by staff and ward 
managers. 
DCM-NR produces a wide range of data to assess participants’ quality of life and 
quality of care. This can include an average of the participant’s ME values (WIB 
score) that is an indicator of well-being, as well as data on the range and type of 
activities participants were engaged with over the mapping period and the quality 
and quantity of staff interactions they received. 
 
Dependency. Dependency was measured using the Northwick Park Dependency 
Scale (NPDS) (Turner-Stokes et al. 1998). This is a widely used, reliable and valid 
measure of dependency (Siegert & Turner-Stokes, 2010) that is already routinely 
completed in all the clinical neuroscience settings included in this study. It was 
completed by the member of staff most able to complete it, typically a registered 
nurse or ward manager. The NPDS measures the amount of help someone needs 
regarding mobility, personal care, safety awareness, communication and 
behaviour. The NPDS provides a score out of 100, with a greater score indicating 
more care needs and therefore higher dependency. 
 
Cognitive Impairment. When considering how best to measure depression in an 
inpatient acquired brain injury population, the benefits of an in-depth 
neuropsychological assessment ere weighed against the impact on the participants 
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completing such an assessment. Consideration was also given to the potential 
difficulties in completing a battery of neuropsychological measures in an acute 
hospital setting. A more in-depth neuropsychological assessment would have 
provided more detailed information but a large proportion of potential participants 
may have been unable to complete the assessment and thus would have been 
excluded from the research. A brief screening measure would enable an 
assessment and judgement of level of cognitive impairment to be made with a 
wider range of participants while also being less taxing on participants. As this 
study sought to include as much of the clinical neuroscience population as possible 
it was decided that a brief screening measure was sufficient for the purposes of 
testing the hypotheses of this research. Of the available measures the 
Addenbrooke’s Cognitive Examination – Revised (ACE-R: Mioshi, Dawson, 
Mitchell, Arnold, & Hodges, 2006) was chosen due to its prior validation in 
neuroscience settings (Gaber, 2008) and its ability to detect mild cognitive 
impairment (Crawford, Whitnall, Robsertson, & Evans, 2012).The ACE-R included 
and expanded upon the MMSE (Folstein et al. 1975) to measure the following 
cognitive domains: attention and orientation, memory, verbal fluency, language and 
visuospatial abilities.  
Participants were classified into four categories of cognitive impairment: severe, 
moderate, mild, and no cognitive impairment. Categorisation was completed using 
a combination of clinical judgement by an experienced clinician and the ACE-R as 
a standard measure of cognitive impairment. Clinical judgment was used to initially 
determine those participants who were unable to complete the ACE-R, e.g. those 
participants in a minimally conscious state or in post-traumatic amnesia (PTA) as it 
was deemed inappropriate to administer the ACE-R to participants presenting in 
this way. Those participants who could not complete the ACE-R were categorised 
by a qualified and experienced clinician as having ‘severe cognitive impairment’. 
Participants who completed the ACE-R and scored between 75 and 88 were 
categorised as having ‘mild cognitive impairment’ (Crawford et al. 2012). Those 
scoring below 75 were categorised into the ‘moderate cognitive impairment’ group; 
and the final category of ‘no cognitive impairment’ comprised those participants 
scoring above the recommended cut-off of 88 (Crawford et al. 2012; Gaber, 2008; 
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Mioshi et al. 2006). In addition, those participants with a spinal injury who were 
deemed to have no cognitive impairment by an experienced clinician were also 
classified in the ‘no cognitive impairment group’.  
Due to the dynamic nature of inpatient wards and the variable presentation of the 
participants, it was not possible to administer the ACE-R to all those who may have 
been able. Where uncertainty of level of cognitive impairment existed, an 
experienced and qualified clinician consulted the patient medical records to 
categorise the participants. 
 
Procedure 
Staff members were informed at least one week prior to mapping about the 
research project and what it would entail. Patients were approached, at least 24 
hours before the start of mapping, using convenience sampling, and informed 
about the research project by an experienced clinician. Formal consent was sought 
from both staff members and patients at least 24 hours before mapping was due to 
be undertaken. At the same time, the clinician also assessed capacity and sought 
assent in those cases where the patient was deemed to lack capacity.  
Mapping was conducted as per the DCM-NR manual (Bradford Dementia Group, 
2012) by two researchers (AL and KOH) who had previously established adequate 
(>80%) inter-rater reliability. Mapping was conducted in both a quiet time and 
busier meal time to observe a range of activities on the bay. Typically this involved 
mapping from: 8.30-11am, and 12.30-3pm. One researcher sat in the bay where 
participants were to be mapped, in a position so that they could see and hear all 
participants with minimal movement. Each ward was mapped between two and 
four times either on the same day or on two consecutive days. Following the 
completion of the maps, staff and patient participants were thanked for their 
participation. It was at this time that those participants who were able were 
approached and asked to complete the ACE-R. All ACE-Rs were administered by 
a single researcher. Following the completion of the ACE-R the participant was 
debriefed about the research project and offered the opportunity to ask questions. 
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Data were analysed as per DCM-NR guidelines (Bradford Dementia Group, 2012) 
and the results disseminated to the staff teams via feedback sessions. Twenty-six 
people completed the ACE-R, and their scores ranged from 54/100 to 95/100, with 
a mean score of 79.96/100 (SD=12.67). A number of participants (n=9) were 
unable to complete items from the visuospatial subtest which required drawing, 
due to motor impairments. In these cases missing data were replaced with the 
mean score from that subscale. The number of participants in each of the four 
categories of severity of cognitive impairment (None, Mild, Moderate & Severe) is 
shown in Table 1. It was not possible to categorise one participant into one of 
these four categories because of inconclusive medical records; therefore, they 
were excluded from analyses involving cognitive impairment.  
Inter-rater reliability above the recommended 80% (Bradford Dementia Group, 
2012) was achieved and maintained for both researchers during the course of 
mapping.  Mood and engagement (ME) values, an indicator of the level of mood 
and engagement of each participant, were recorded on a six point scale at -5, -3, -
1, +1, +3, and +5, with positive values reflecting positive mood and engagement. 
ME values were recorded every 3 minutes giving a maximum of 50 ME values for 
each participant. Participant WIB scores, an index of the participant’s relative well-
being over the mapped time period, were calculated by averaging each 
participant’s ME values over the whole time-frame. WIB scores ranged from -0.50 
to 2.16 with a mean of 1.15 (SD = 0.65). 
Potential for positive engagement was calculated as the percentage of time spent 
in behaviours that have a high potential for well-being over the time-frame. 
Behaviours with a high potential for well-being include: leisure, personal care, 
eating and talking with others Mean PPE was 62.75% (SD = 28.18%) with a range 
of 2-100%. A significantly positive correlation, using Spearman’s Rho, between 
WIB scores and PPE was detected at the .01 level (two tailed) (rs=.620, n=66, 
p=.001). 
Personal enhancers (PEs) and personal detractors (PDs) per individual were not 
recorded because there was little staff-patient interaction. Overall, there were more 
PEs (76%) than PDs (24%). Many PEs were meeting the patients’ needs for 
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comfort, but examples of staff-patient interaction were found for all five 
psychological needs of attachment, identity, occupation, inclusion and the 
aforementioned comfort. PDs, although less numerous, were more evenly spread 
among the five psychological needs. For a more thorough description of the DCM-
NR data, its acceptability and psychometric properties see O’Halnlon et al. (In 
preparation). 
Kolmogorov-Smirnov tests of normality were completed for participant scores on 
the NPDS, and their WIB scores and their PPE scores. WIB scores (0.099, p = 
.192) and NPDS scores (0.105, p = .074) were considered to be normally 
distributed (.05 significance level). PPE, however, was not normally distributed at a 
.05 significance level (0.133, p = .006).  
 
Results 
Sixty seven participants either gave consent, or a nominated person gave advice 
on their best wishes, and were included in the study. It was not possible to access 
two participants’ medical records, giving a final sample size of 65. See Table 1 for 
a description of participant demographics. 
Hypothesis 1: Analysis of dependency and DCM 
To test Hypothesis 1a, a Pearson’s correlation was conducted between NPDS and 
WIB scores, with a significant negative correlation detected (r = -.447, n = 64, p 
<.001).  
To test Hypothesis 1b, a Spearman’s Rho correlation was performed between PPE 
and NPDS scores, with a significant negative correlation detected (rs = -.376, n = 
64, p = .002). 
 
Hypothesis 2: Analysis of Cognitive Impairment & DCM 
To test hypothesis 2a, a one-way independent samples ANOVA was conducted to 
compare the effect of cognitive impairment on WIB scores. There was a significant 
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effect of cognitive impairment on WIB scores at the p < .05 level for the four 
categories F(3, 60) = 9.910, p <.001). Post hoc comparisons using Tukey’s Test 
were completed. A significant difference in mean WIB scores was found between 
the severe (M=0.36, SD=0.59) and all other categories of cognitive impairment at 
the .05 level. No significant difference in means was found between the mild 
(M=1.39, SD=0.56), moderate (M=1.30, SD=0.45) or no cognitive impairment 
(M=1.35, SD=0.54) categories. Figure 1 shows the mean WIB scores for each of 
the four levels of cognitive impairment.  
To test Hypothesis 2b a one-way independent sample ANOVA was conducted to 
determine the effect of cognitive impairment on potential for positive engagement 
(PPE). A significant effect of cognitive impairment on PPE at the p<.05 level for the 
four categories F (3, 60) = 5.20, p=.003) was found. Post hoc comparisons 
revealed a significant difference between the severe categories of cognitive  
Figure.1 Boxplot showing WIB scores for categories of cognitive impairment. 
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category (M=36.66, SD=23.46) and the mild (M=74.02, SD=15.42) and no 
cognitive impairment (M=70.54, SD=27.42) categories. No significant difference 
was detected between the moderate cognitive impairment category (M=60.87, 
SD=30.27) and any other category.   
 
Hypothesis 3: Analysis of Cognitive Impairment & Dependency 
To test hypothesis 3, a one-way independent samples ANOVA was conducted to 
determine the effect of cognitive impairment on dependency. There was a 
significant effect of cognitive impairment on NPDS scores at the p>.05 level for the 
four categories F (3, 59) = 7.533, p<.001). Post hoc analysis revealed a significant 
difference between the severe cognitive impairment category (M=49.09, 
SD=14.59) and the mild (M=25.40, SD=17.19) and no cognitive impairment 
(M=20.54, SD=17.78) categories. No other significant difference in dependency 
was detected between the cognitive impairment categories.  
Cognitive impairment and NPDS scores, significantly predicted WIB scores and 
PPE. Therefore, to further investigate these predictive effects, and thus hypotheses 
1 and 2, multiple regression analyses were conducted. 
With regards to WIB scores, a standard multiple regression was calculated and 
using the enter method a significant model was determined F(2, 60) = 10.75, 
p<.001, which accounted for approximately 23.9% of the variance in WIB scores 
(adjusted R2 = .239) with significant predictor variables, at the .05 level, of 
Cognitive Impairment (β = -0.291, p=.026) and Dependency (β=-0.303, p=.021). 
Multiple regression analysis was used to test if cognitive impairment and 
dependency predicted PPE. The results of the regression indicated that the two 
predictor variables accounted for 17.2% of the variance in PPE scores (Adjusted 
R2 = 0.172, F(2,60) = 7.45, P<.001). Cognitive impairment (β=-0.277, p=.042) 
predicted PPE alone; however, dependency (β = -0.239, p=.077) did not predict 
PPE alone. 
 
17 
 
Discussion 
The results of this study support all three hypotheses. Relationships were identified 
between dependency and well-being (WIB scores) and behaviours with the 
potential to lead to greater well-being (PPE scores). This supports the majority of 
previous research that those patients with greater dependency were observed to 
have lower well-being using Dementia Care Mapping (Edelman, et al 2004). 
Cognitive impairment was identified as being a predictor of well-being and of 
potential for positive engagement. The prior evidence into how cognitive 
impairment affects DCM observations was unclear (Brooker, 2005); however, the 
results of this study support those of Edelman et al. (2004). Those participants with 
severe cognitive impairment were consistently observed to be in significantly lower 
well-being states and engaging in fewer behaviours leading to well-being. This 
finding is unsurprising given the wider range of cognitive impairment in this study 
than is usually seen in dementia settings. Several patients in the severe cognitive 
impairment category were in post-traumatic amnesia or minimally-conscious 
states. With regard to the relationship between cognitive impairment and 
dependency, the current study supports the consensus that greater cognitive 
impairment leads to greater dependency (Seel et al. 2003; Vickery, et al 2005). 
The interaction of these two factors in influencing well-being is less clear and the 
present data demonstrate that both dependency and cognitive impairment 
contribute equally to the variance in well-being scores and potential for positive 
engagement.  This indicates that patients in clinical neuroscience settings are 
particularly at risk of being in lower states of wellbeing, thus highlighting the need 
for systemic intervention in these settings. DCM-NR may meet this need since 
repeated rounds of DCM in an organisation supportive of PCC has been 
demonstrated as efficacious in improving well-being, particularly in those with 
higher levels of dependency and cognitive impairment (Brooker et al., 1998). 
Personal enhancers (PEs) and detractors (PDs) were not recorded for individual 
patients which prevented a direct comparison between staff–patient interaction and 
the level of dependency or cognitive impairment of the patient. However, it was 
noted that those patients with lowest levels of cognitive impairment and 
dependency, and importantly able to reciprocate positive interactions from staff, for 
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example by laughing, were in receipt of more positive interactions and thus PEs. 
This would result in further improving the well-being of those patients who were 
either already in a high well-being state or had the potential to be in a high well-
being state. Patients engaged in a positive activity had more opportunity for staff–
patient interaction that those patients withdrawn or in pain. However, positive staff–
patient interactions were noted with those patients in distress/pain, possibly 
resulting in the high number of interactions providing comfort to the patient. 
Improvements in staff–patient interactions with those patients at most need of such 
could likely be achieved through repeated rounds of DCM-NR as part of a systemic 
intervention on improving person-centred care. 
The adaptations made to DCM to producing DCM-NR for use in clinical 
neuroscience settings were found to be appropriate in the current study. No major 
difficulties with assigning behaviour category codes or well-ill being values were 
identified; furthermore, the addition of certain codes to reflect the inpatient setting, 
e.g., curtains being closed around the hospital bed, were useful. The use of three-
minute timeframes and of a single mapper-per-bay did not appear to detract from 
the ability to measure person centred care in this study.  
The strengths of this study lie in the range of neuroscience settings used, allowing 
for generalisations to be made more confidently. DCM-NR had previously only 
piloted in a single neurorehabilitation setting (McIntosh et al. 2012; Westbrook et 
al. 2013). The range of settings included acute neurology, neurosurgery, and 
neurorehabilitation, resulting in a heterogeneous sample. While a heterogeneous 
sample aided the generalisability of the findings from this study, the heterogeneity 
of participants led to difficulties in measuring cognitive impairment. Both the range 
of neuroscience settings and the wide range of participants included in this study 
strengthen the findings of this research in terms of ecological validity. To enhance 
the findings of this study further, DCM-NR could be applied to more intermediate 
and community-based neuroscience settings. 
The adaptations to the DCM-NR approach, namely shorter time-frames and shorter 
observation periods, demonstrate the continuing efficacy of DCM-NR in line with 
recommendations of previous research. It is considered that the adaptations may 
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make the tool more acceptable due to the reduced demand on staff time. Another 
strength of this study is that it builds upon the DCM research conducted in 
dementia care settings and demonstrates the importance of those same issues in 
clinical neuroscience settings. Brooker (2005) argued that dependency should be 
recorded alongside DCM due to the potential for dependency to affect DCM 
scores. In findings that dependency leads to lower DCM scores, this study 
supports the importance of measuring dependency alongside DCM-NR. 
Furthermore, research by Edelman et al. (2004) demonstrated that cognitive 
impairment impacts on DCM scores, in dementia care settings, and this study 
found comparable results in the clinical neuroscience population. 
There were several limitations of this study inherent within its design. Observation-
expectancy effects on staff and patients have been indicated in previous DCM 
research (Westbrook et al., 2013). The presence of an observer may have led to a 
change in staff interactions with patients resulting in an overestimation of patients’ 
well-being. However, the presence of an observer may also have deterred staff 
from entering the observed bay for reasons other than essential/required care 
tasks. The choice of time to observe may also have led to biased results. The time 
periods mapped were considered representative by staff, and previous DCM 
research had established that mapping during lunchtime was representative of the 
whole day (Fulton et al., 2006) for health and social care dementia settings. 
However, there was no objective indication that the time mapped in the current 
study was representative of the day as a whole, due to DCM-NR research being in 
its infancy. The findings of Fulton et al. (2006) may not apply to acute hospital 
settings and further research is needed to establish periods of the day 
representative of the day as a whole; this would be inherently difficult due to 
varying ward timetables, visiting hours, and staff shifts. For example, staff reported 
during feedback sessions that night-shifts may exhibit less person-centred care 
than day-shifts. 
The Addenbrooke’s Cognitive Examination – Revised (ACE-R: Moshi et al. 2006) 
was chosen as a measure of cognitive impairment for its ability to reliably detect 
mild cognitive impairment (Crawford et al. 2012). The ACE-R was originally 
designed to detect the cognitive impairment present in fronto-temporal-dementia 
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and while it has been shown to be valid in a brain injury setting, its use in this study 
was problematic. Firstly, the measurement of cognitive impairment exceeded the 
scope of the ACE-R with some participants too severely cognitively impaired to 
attempt the measure. This resulted in the severe cognitive impairment group being 
comprised of a wide range of patients, for example, from people who could 
communicate to people in a minimally conscious state. The lack of a standardised 
measure feasible for use across the severity range of cognitive impairment meant 
that clinical judgement was necessary to categorise those people unable to 
complete the ACE-R. Secondly, over a third of participants were unable to 
complete items on the visuo-spatial subscale due to motor impairments (e.g. 
hemiparesis) independent of cognitive impairment. Lastly, it was necessary to 
administer the ACE-R by the bedside of participants which resulted in a number of 
distractions and interruptions. Although every effort was made to minimise 
distractions, e.g., by using a side room or closing curtains around their bed, 
distractions likely had a detrimental effect on participant performance on the ACE-
R. Despite previously research indicating its validity (Gaber, 2008), the difficulty in 
using the ACE-R in the current study raises the case for the development of a 
standardised measure of the full range of cognitive impairment in clinical inpatient 
neuroscience settings.  
There are a number of implications for future research from the current study. The 
need for a brief measure of cognitive impairment, for use with a broad range of 
cognitive impairment in patients residing in an acute hospital setting, has been 
discussed. The current study identified that those patients with severe cognitive 
impairment were more likely to be in states of lower well-being. Cognitive 
impairment is a broad term and comprises many functions. In order to better tailor 
cognitive rehabilitation, more research needs to be done to determine which 
domains of cognitive impairment impact on wellbeing the most and how 
rehabilitation can target these domains. A study employing DCM (Potkins et al., 
2003) found that extent of language impairment was significantly correlated with 
social withdrawal, reduced engagement in activities, and level of depression. 
DCM is regarded as both a set of observational tools and as a process to improve 
PCC. Most of the amendments to produce DCM-NR and subsequent research 
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using DCM-NR or DCM research in neurorehabilitation populations has looked 
primarily at the use of the tool and not the process. While both the tool and process 
were deemed to be acceptable and feasible to staff and patients in initial pilot 
studies (Stevens et al., in progress; McIntosh et al., 2012) and the feasibility further 
established in a range of neurorehabilitation settings (O’Hanlon, in preparation), 
more research is required to develop the utility of DCM-NR as a process of 
improving PCC. Evaluating the effectiveness of DCM-NR in improving PCC such 
as through the use of an intervention design study would help empower arguments 
for DCM-NR to become embedded in clinical neuroscience settings with the aim of 
improving PCC. 
Following the findings of the Francis Report (2013), there is a need for an 
observational measure of person-centred care and patient well-being in acute 
hospital settings. The current study adds to the evidence base indicating that DCM-
NR is effective in this regard. The current study also showed that patients with high 
levels of dependency and/or severe cognitive impairment are less likely to engage 
in behaviours with the potential for well-being and more likely to be in a state of low 
well-being, thus identifying risk factors for diminished well-being. Those patients 
with high levels of dependency or severe cognitive impairment warrant increased 
focus and attention and DCM-NR is a way of ensuring their person-centred care 
needs are addressed. Clinical neuroscience settings are more likely than most 
general wards in acute hospitals to have patients with severe cognitive impairment 
suggesting that the use of DCM-NR is particularly pertinent in those settings. 
Similarly, high dependency and intensive care wards have patients who would 
benefit from routine care mapping to improve patient well-being and person-
centred care. Repeated rounds of DCM in an organisation supportive of PCC has 
been demonstrated as efficacious in improving well-being, particularly in those with 
higher levels of dependency and cognitive impairment (Brooker et al., 1998). 
This study demonstrates that those patients with greater cognitive impairment and 
higher levels of dependency were observed to have lower well-being and that they 
engaged in behaviours less likely to lead to well-being. This study supported the 
implementation of DCM-NR to measure well-being and person-centred care in 
clinical neuroscience settings. Further research should focus on using DCM-NR to 
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improve person-centred care in these settings with a particular focus on how the 
well-being of those patients with severe cognitive impairment or high dependency 
could be improved.  
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